The National Institutes of Health yesterday awarded a total of $78 million in funding to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, with the goal of bringing to market as soon as this year new home and point-of-care tests that can detect multiple respiratory infections.

“The potential to test simultaneously for multiple types of infection at the point-of-care, is a new frontier that we hope to advance and could be a major step toward transforming U.S. healthcare,” said Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering.

 

Related News Articles

News
President Biden today called the new Omicron variant of the COVID-19 virus “a cause for concern, not a cause for panic,” urging all eligible Americans to get…
News
The U.S. District Court for the Eastern District of Missouri today granted a preliminary injunction preventing the Centers for Medicare & Medicaid Services…
Headline
A two-dose series of the Pfizer-BioNTech COVID-19 vaccine was 100% effective against COVID-19 in 12-15 year olds more than four months after the second dose in…
Headline
The Department of Health and Human Services today began distributing $7.5 billion of the $8.5 billion in American Rescue Plan Act payments designated for…
Headline
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., Friday expanded eligibility for COVID-19 booster shots to include all adults…
Headline
The Health Resources and Services Administration in September gave health care providers who received more than $10,000 in Provider Relief Funds between April…